Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):1002–1009. doi: 10.1097/QAI.0000000000002661

Table 2:

Association among 314 dolutegravir recipients between percentage weight gain at week 48 and selected polymorphisms relevant to dolutegravir

SNPa Gene MAFc Beta P-valued
rs13137622 ABCG2 0.46 −1.24 0.03
rs2725252 ABCG2 0.19 −1.29 0.06
rs1042640 UGT1A1 0.18 1.34 0.07
rs10929302 UGT1A1 0.29 1.01 0.09
rs28401781 ABCB1 0.25 −1.12 0.09
rs2246709 CYP3A4 0.31 −0.94 0.12
rs1976391 UGT1A1 0.41 0.84 0.13
rs887829b UGT1A1 0.41 0.81 0.15
rs2231137 ABCG2 0.06 1.73 0.16
rs10011796 ABCG2 0.25 −0.92 0.16
rs12505410 ABCG2 0.1 −1.1 0.24
rs4148738 ABCB1 0.14 −0.89 0.25
rs4124874 UGT1A1 0.37 0.92 0.26
rs3789243 ABCB1 0.38 0.66 0.27
rs1922242 ABCB1 0.45 0.59 0.28
rs10276036 ABCB1 0.15 −0.81 0.28
rs1045642 ABCB1 0.89 0.93 0.35
rs3842 ABCB1 0.28 0.55 0.36
rs2235015 ABCB1 0.36 0.47 0.41
rs3213619 ABCB1 0.17 0.55 0.47
rs10248420 ABCB1 0.35 0.4 0.5
rs2235067 ABCB1 0.15 −0.42 0.6
rs10267099 ABCB1 0.1 0.49 0.6
rs1128503 ABCB1 0.06 0.59 0.61
rs2740574 CYP3A4 0.25 −0.3 0.62
rs11983225 ABCB1 0.21 −0.26 0.72
rs3735451 CYP3A4 0.17 0.24 0.76
rs4646440 CYP3A4 0.08 −0.28 0.78
rs4728709 ABCB1 0.39 0.15 0.79
rs4148740 ABCB1 0.19 −0.17 0.81
rs2242480 CYP3A4 0.14 0.19 0.82
rs7699188 ABCG2 0.44 −0.12 0.83
rs3114020 ABCG2 0.15 −0.17 0.83
rs8330 UGT1A1 0.4 0.12 0.84
rs10280101 ABCB1 0.2 −0.11 0.88
rs4646437 CYP3A4 0.13 0.09 0.92
rs2235047 ABCB1 0.23 −0.05 0.94
rs10929303 UGT1A1 0.37 −0.03 0.95
rs7787082 ABCB1 0.27 −0.02 0.97
rs2235040 ABCB1 0.17 −0.02 0.98
a

SNP: Single nucleotide polymorphism.

b

UGT1A1 rs887829 T allele is known to be in strong linkage disequilibrium (LD) with the Gilbert trait decrease expression allele, UGT1A1*28.

c

MAF: Minor allele frequency.

d

Significance threshold was 1.0×10−3 for the subset of 40 polymorphisms.